Catalyst Pharmaceutical CPRX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's total equity?
- Catalyst Pharmaceutical (CPRX) reported total equity of $1.01B in Q1 2026.
- How has Catalyst Pharmaceutical's total equity changed year-over-year?
- Catalyst Pharmaceutical's total equity increased by 27.5% year-over-year, from $794.28M to $1.01B.
- What is the long-term trend for Catalyst Pharmaceutical's total equity?
- Over 5 years (2020 to 2025), Catalyst Pharmaceutical's total equity has grown at a 41.3% compound annual growth rate (CAGR), from $169.6M to $954.27M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.